NewsCBDEurope’s Glaring National Differences Over CBD

Europe’s Glaring National Differences Over CBD

-

OVER three quarters of Brits are familiar with CBD, whilst in France, just over one-third aware of it.

The French are also the most sceptical of CBD whilst their Swiss neighbours are the most engaged, European research has revealed.

The findings from New Frontier Data found French respondents are least likely to agree that CBD had valid medical uses – at 46% – nine points less than the rest of Europe.

Whilst they are also the most likely to believe that CBD should only be available with a doctor’s recommendation, at 49%, compared to 36% on the rest of the continent.

Meanwhile, in Switzerland and Austria more than half – 53% – are positive about CBD, compared to 42% of Europeans overall.

The October 2019 European CBD Survey polled 3,100 respondents from the continent about their attitudes and CBD use.

It found that most consumers are using CBD to treat, pain, at 40%, for relaxation, at 34%, and to reduce stress and anxiety levels at 31% and 26% respectively.

In relation to CBD usage the French were once again at the bottom with 7% compared to 16% of all Europeans.

There is also a marked difference in familiarity with cannabidiol – or CBD – in France at 36% compared to 78% in the United Kingdom and Ireland. 

However, this French scepticism towards CBD, and all things cannabis, is currently under attack from two sides.

Earlier this year the Government approved the country’s first medical cannabis trial, and the French Parliament looks set to ease restrictions on the CBD wellness market.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Tetra Pharm Technologies Secures €9 Million In Series A Round To Expand R&D Operations

PRESS RELEASE THE Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a...

European Cannabis Stocks Review: OCT Shares Fall As Co-Founder Divests, Cannabis Poland Secures Funding, & Akanda’s Legal Battle Continues

Oxford Cannabinoid Technologies  THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the...

European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia...

FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.  On Tuesday,...

22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK And EU Market Position

PRESS RELEASE 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...

Czechia Could Be A ‘Step Towards Convincing The Rest Of Europe To Create A Legal Cannabis Framework’

EARLIER this week, Czechia’s national anti-drug coordinator Jindřich Vobořil, described as the ‘locomotive’ driving rapid cannabis reform in the...

Hellenic Dynamics ‘On Track’ To Supply Flowers To Germany By Mid 2023

PRESS RELEASE Hellenic Dynamics' core strategy is to develop and operate its 40,000 square metre active THC cultivation licence from...

Must read

You might also likeRELATED
Recommended to you